弱毒生水痘ワクチンの世界市場2020

【英語タイトル】Global Varicella Attenuated Live Vaccine Market Research Report 2020

QYResearchが出版した調査資料(QYR3883013)・商品コード:QYR3883013
・発行会社(調査会社):QYResearch
・発行日:2020年10月
・ページ数:約110
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥301,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD4,350 ⇒換算¥452,400見積依頼/購入/質問フォーム
Enterprise License(法人閲覧用)USD5,800 ⇒換算¥603,200見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、弱毒生水痘ワクチンの世界市場について調査・分析し、弱毒生水痘ワクチンの市場動向、種類別市場規模、用途別市場規模、地域別市場規模、主要企業別市場シェア・企業情報などを含め、以下の構成でお届けいたします。
【レポートの概要】

The global Varicella Attenuated Live Vaccine market was valued at US$ 0 million in 2019 and is expected to reach US$ 0 million by the end of 2026, growing at a CAGR of 0 during 2020-2026.
This report focuses on Varicella Attenuated Live Vaccine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Varicella Attenuated Live Vaccine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, Japan, etc.
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
 Monovalent Vaccine
 Combination Vaccine

Segment by Application
 Kids Injection
 Adults Injection

By Region
 North America
 U.S.
 Canada
 Asia-Pacific
 China
 Japan
 South Korea
 India
 Australia
 Taiwan
 Indonesia
 Thailand
 Malaysia
 Europe
 Germany
 France
 U.K.
 Italy
 Russia
 Latin America
 Mexico
 Brazil
 Argentina
 Middle East & Africa
 Turkey
 Saudi Arabia
 U.A.E

By Company
 Merck
 GSK
 BCHT
 Changsheng
 Keygen
 Green Cross
 Biken

【レポートの目次】

1 VARICELLA ATTENUATED LIVE VACCINE MARKET OVERVIEW
1.1 Product Overview and Scope of Varicella Attenuated Live Vaccine
1.2 Varicella Attenuated Live Vaccine Segment by Type
1.2.1 Global Varicella Attenuated Live Vaccine Sales Growth Rate Comparison by Type (2020-2026)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Varicella Attenuated Live Vaccine Segment by Application
1.3.1 Global Varicella Attenuated Live Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Global Varicella Attenuated Live Vaccine Market Size Estimates and Forecasts
1.4.1 Global Varicella Attenuated Live Vaccine Revenue 2015-2026
1.4.2 Global Varicella Attenuated Live Vaccine Sales 2015-2026
1.4.3 Varicella Attenuated Live Vaccine Market Size by Region: 2020 Versus 2026
2 VARICELLA ATTENUATED LIVE VACCINE MARKET COMPETITION BY MANUFACTURERS
2.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Varicella Attenuated Live Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Varicella Attenuated Live Vaccine Market Competitive Situation and Trends
2.5.1 Varicella Attenuated Live Vaccine Market Concentration Rate
2.5.2 The Global 5 and 10 Largest Varicella Attenuated Live Vaccine Players Market Share by Revenue
2.5.3 Global Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Varicella Attenuated Live Vaccine Players (Opinion Leaders)
3 VARICELLA ATTENUATED LIVE VACCINE RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Varicella Attenuated Live Vaccine Market Facts & Figures by Country
3.3.1 North America Varicella Attenuated Live Vaccine Sales by Country
3.3.2 North America Varicella Attenuated Live Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Varicella Attenuated Live Vaccine Market Facts & Figures by Country
3.4.1 Europe Varicella Attenuated Live Vaccine Sales by Country
3.4.2 Europe Varicella Attenuated Live Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Varicella Attenuated Live Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Varicella Attenuated Live Vaccine Sales by Region
3.5.2 Asia Pacific Varicella Attenuated Live Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.6 Latin America Varicella Attenuated Live Vaccine Market Facts & Figures by Country
3.6.1 Latin America Varicella Attenuated Live Vaccine Sales by Country
3.6.2 Latin America Varicella Attenuated Live Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Varicella Attenuated Live Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Varicella Attenuated Live Vaccine Sales by Country
3.7.2 Middle East and Africa Varicella Attenuated Live Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 VARICELLA ATTENUATED LIVE VACCINE HISTORIC MARKET ANALYSIS BY TYPE
4.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Varicella Attenuated Live Vaccine Price by Type (2015-2020)
4.4 Global Varicella Attenuated Live Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 VARICELLA ATTENUATED LIVE VACCINE HISTORIC MARKET ANALYSIS BY APPLICATION
5.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Varicella Attenuated Live Vaccine Price by Application (2015-2020)
6 COMPANY PROFILES AND KEY FIGURES IN VARICELLA ATTENUATED LIVE VACCINE BUSINESS
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Merck Varicella Attenuated Live Vaccine Products Offered
6.1.5 Merck Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 GSK Varicella Attenuated Live Vaccine Products Offered
6.2.5 GSK Recent Developments
6.3 BCHT
6.3.1 BCHT Corporation Information
6.3.2 BCHT Description and Business Overview
6.3.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 BCHT Varicella Attenuated Live Vaccine Products Offered
6.3.5 BCHT Recent Developments
6.4 Changsheng
6.4.1 Changsheng Corporation Information
6.4.2 Changsheng Description and Business Overview
6.4.3 Changsheng Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Changsheng Varicella Attenuated Live Vaccine Products Offered
6.4.5 Changsheng Recent Developments
6.5 Keygen
6.5.1 Keygen Corporation Information
6.5.2 Keygen Description and Business Overview
6.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Keygen Varicella Attenuated Live Vaccine Products Offered
6.5.5 Keygen Recent Developments
6.6 Green Cross
6.6.1 Green Cross Corporation Information
6.6.2 Green Cross Description and Business Overview
6.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Green Cross Varicella Attenuated Live Vaccine Products Offered
6.6.5 Green Cross Recent Developments
6.7 Biken
6.7.1 Biken Corporation Information
6.7.2 Biken Description and Business Overview
6.7.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.7.4 Biken Varicella Attenuated Live Vaccine Products Offered
6.7.5 Biken Recent Developments
7 VARICELLA ATTENUATED LIVE VACCINE MANUFACTURING COST ANALYSIS
7.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine
7.4 Varicella Attenuated Live Vaccine Industrial Chain Analysis
8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS
8.1 Marketing Channel
8.2 Varicella Attenuated Live Vaccine Distributors List
8.3 Varicella Attenuated Live Vaccine Customers
9 VARICELLA ATTENUATED LIVE VACCINE MARKET DYNAMICS
9.1 Varicella Attenuated Live Vaccine Market Trends
9.2 Varicella Attenuated Live Vaccine Opportunities and Drivers
9.3 Varicella Attenuated Live Vaccine Challenges
9.4 Porter’s Five Forces Analysis
10 GLOBAL MARKET FORECAST
10.1 Varicella Attenuated Live Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Type (2021-2026)
10.2 Varicella Attenuated Live Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Application (2021-2026)
10.3 Varicella Attenuated Live Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Varicella Attenuated Live Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Varicella Attenuated Live Vaccine by Region (2021-2026)
11 RESEARCH FINDINGS AND CONCLUSION
12 METHODOLOGY AND DATA SOURCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer



★調査レポート[弱毒生水痘ワクチンの世界市場2020] (コード:QYR3883013)販売に関する免責事項を必ずご確認ください。
★調査レポート[弱毒生水痘ワクチンの世界市場2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆